Active smoking is associated with the development of adverse events of biological therapy in patients with inflammatory bowel disease. Theodoraki E, Orfanoudaki E, Petroulaki E, Foteinogiannopoulou K, et al. Eur J Gastroenterol Hepatol 2022 Sep 12. pii: 00042737-990000000-00073.

Read + Share

Amedeo Smart

Independent Medical Education

Theodoraki E, Orfanoudaki E, Petroulaki E, Foteinogiannopoulou K, et al. Active smoking is associated with the development of adverse events of biological therapy in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2022 Sep 12. pii: 00042737-990000000-00073.
PMID: 36165073